Literature DB >> 7047718

The effect of captopril (SQ14,225) upon mother and fetus in the chronically cannulated ewe and in the pregnant rabbit.

F Broughton Pipkin, E M Symonds, S R Turner.   

Abstract

1. An inhibitor of angiotensin-I-converting enzyme activity (D-3-mercapto-2-methylpropanoyl-L-proline, Captopril) was given to five chronically cannulated pregnant ewes and eleven rabbits in late pregnancy. 2. Within 2 min of administration to the sheep, Captopril had blocked the maternal conversion of angiotensin I to II, as assessed by the pressor response evoked by the i.v. administration of angiotensin I. Maternal and fetal basal systemic blood pressures had fallen within 10 min of administration. Although maternal systemic blood pressure returned to basal levels within 2 hr, fetal pressures remained low for up to 2 days. 3. All ewes went into spontaneous labour at or near term. One lamb was live-born but very weak and failed to establish suckling. The remaining seven lambs were fresh still-births. 4. Gestation length was significantly prolonged in the treated rabbits by comparison with ten controls. The still-birth rate was 37% in the treated animals and 6% in the controls (P less than 0.001). 5. It is concluded that the administration of Captopril to the two species studied is harmful to the fetus. The observations suggest that the drug rapidly crosses the placenta, and may cross the blood-brain barrier to exert a central effect. It may also interfere with the normal initiation of parturition.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7047718      PMCID: PMC1250365          DOI: 10.1113/jphysiol.1982.sp014081

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  14 in total

1.  The mechanism of initiation of parturition in the ewe.

Authors:  G C Liggins; R J Fairclough; S A Grieves; J Z Kendall; B S Knox
Journal:  Recent Prog Horm Res       Date:  1973

2.  Effect of the specific angiotensin antagonist (Sar1) (Ala8) angiotensin II on blood pressure and the renin-angiotensin system in the conscious pregnant ewe and fetus.

Authors:  F Broughton Pipkin; P M O'Brien
Journal:  Am J Obstet Gynecol       Date:  1978-09-01       Impact factor: 8.661

3.  Pregnancy hypertension, parity, and the renin-angiotensin system.

Authors:  E M Symonds; F Broughton Pipkin
Journal:  Am J Obstet Gynecol       Date:  1978-11-01       Impact factor: 8.661

4.  Inhibitors of the renin-angiotensin system in experimental hypertension, with a note on the measurement of angiotensin I, II and III during infusion of converting-enzyme inhibitor.

Authors:  J J Morton; J Casals-Stenzel; A F Lever; J A Millar; A J Riegger; M Tree
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

5.  Changes in the renin-angiotensin system in primigravidae with hypertensive disease of pregnancy.

Authors:  E M Symonds; F Broughton Pipkin; D J Craven
Journal:  Br J Obstet Gynaecol       Date:  1975-08

6.  Haemodynamic effects of captopril in hypertensive patients: comparison with saralasin.

Authors:  R Fagard; A Amery; P Lijnen; T Reybrouck
Journal:  Clin Sci (Lond)       Date:  1979-12       Impact factor: 6.124

7.  Plasma renin and aldosterone in pregnancy complicated by adrenal insufficiency.

Authors:  E M Symonds; D J Craven
Journal:  Br J Obstet Gynaecol       Date:  1977-03

8.  A specific orally active inhibitor of angiotensin-converting enzyme in man.

Authors:  R K Ferguson; G A Turini; H R Brunner; H Gavras; D N McKinstry
Journal:  Lancet       Date:  1977-04-09       Impact factor: 79.321

9.  Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man.

Authors:  S L Swartz; G H Williams; N K Hollenberg; L Levine; R G Dluhy; T J Moore
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

10.  Factors affecting angiotensin II concentrations in the human infant at birth.

Authors:  F Broughton Pipkin; E M Symonds
Journal:  Clin Sci Mol Med       Date:  1977-05
View more
  24 in total

Review 1.  Comparative risk-benefit assessment of drugs used in the management of hypertension in pregnancy.

Authors:  P M Kyle; C W Redman
Journal:  Drug Saf       Date:  1992 May-Jun       Impact factor: 5.606

Review 2.  The treatment of hypertension in pregnancy. Clinical pharmacokinetic considerations.

Authors:  C Knott
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

Review 3.  Anaesthesia and pre-eclampsia.

Authors:  D H Morison
Journal:  Can J Anaesth       Date:  1987-07       Impact factor: 5.063

Review 4.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

5.  Comparison of angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition in pregnant sheep during late gestation.

Authors:  A J Forhead; K Whybrew; P Hughes; F Broughton Pipkin; M Sutherland; A L Fowden
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

Review 6.  Hypertension in pregnancy.

Authors:  E M Symonds
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-03       Impact factor: 5.747

7.  The effect of saralasin in the chronically cannulated ewe in the early puerperium.

Authors:  F Broughton Pipkin; S R Turner; C Wallace
Journal:  J Physiol       Date:  1984-01       Impact factor: 5.182

8.  The effect of enalapril (MK421), an angiotensin converting enzyme inhibitor, on the conscious pregnant ewe and her foetus.

Authors:  F Broughton Pipkin; C P Wallace
Journal:  Br J Pharmacol       Date:  1986-03       Impact factor: 8.739

Review 9.  Hypertension in pregnancy. Pathophysiology and management.

Authors:  W F Lubbe
Journal:  Drugs       Date:  1984-08       Impact factor: 9.546

Review 10.  Vasodilator factors in the systemic and local adaptations to pregnancy.

Authors:  Gloria Valdes; Peter Kaufmann; Jenny Corthorn; Rafaela Erices; K Bridget Brosnihan; Janae Joyner-Grantham
Journal:  Reprod Biol Endocrinol       Date:  2009-07-31       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.